ICAM1 and neoplasm: Most studies of T cell homing to tumors have focussed on the recruitment of effector T cells into B16 melanomas and shown important roles for P/E-selectin and ICAM-1 on tumor blood vessels as well as CXCR3 ligands (44, 45).